Department of Social Sciences & Health Policy, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Center for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island; Department of Biostatistics, Brown University of Public Health, Providence, Rhode Island.
J Am Coll Radiol. 2023 Oct;20(10):1022-1030. doi: 10.1016/j.jacr.2023.03.021. Epub 2023 Jul 7.
To examine utilization patterns of diagnostic procedures after lung cancer screening among participants enrolled in the National Lung Screening Trial.
Using a sample of National Lung Screening Trial participants with abstracted medical records, we assessed utilization of imaging, invasive, and surgical procedures after lung cancer screening. Missing data were imputed using multiple imputation by chained equations. For each procedure type, we examined utilization within a year after the screening or until the next screen, whichever came first, across arms (low-dose CT [LDCT] versus chest X-ray [CXR]) and by screening results. We also explored factors associated with having these procedures using multivariable negative binomial regressions.
After baseline screening, our sample had 176.5 and 46.7 procedures per 100 person-years for those with a false-positive and negative result, respectively. Invasive and surgical procedures were relatively infrequent. Among those who screened positive, follow-up imaging and invasive procedures were 25% and 34% less frequent in those screened with LDCT, compared with CXR. Postscreening utilization of invasive and surgical procedures was 37% and 34% lower at the first incidence screen compared with baseline. Participants with positive results at baseline were six times more likely to undergo additional imaging than those with normal findings.
Use of imaging and invasive procedures to evaluate abnormal findings varied by screening modality, with a lower rate for LDCT than CXR. Invasive and surgical workup were less prevalent after subsequent screening examinations compared with baseline screening. Utilization was associated with older age but not gender, race or ethnicity, insurance status, or income.
研究国家肺癌筛查试验(National Lung Screening Trial,NLST)参与者肺癌筛查后诊断程序的使用模式。
我们利用有记录摘要的 NLST 参与者样本,评估了肺癌筛查后影像学、有创性和手术程序的使用情况。使用链式方程的多重插补法处理缺失数据。对于每种程序类型,我们根据手臂(低剂量 CT [LDCT] 与胸部 X 线 [CXR])和筛查结果,在筛查后 1 年内或下一次筛查之前(以先发生者为准),评估了这些程序的使用情况。我们还使用多变量负二项回归探索了与这些程序相关的因素。
在基线筛查后,对于假阳性和阴性结果的患者,其每年每 100 人分别有 176.5 次和 46.7 次程序。有创性和手术性程序相对较少。对于筛查阳性的患者,与 CXR 相比,LDCT 筛查者的随访影像学和有创性程序分别减少了 25%和 34%。与基线相比,首次发生率筛查时的侵入性和手术性程序的使用率分别降低了 37%和 34%。基线时结果阳性的患者比正常发现的患者进行额外影像学检查的可能性高 6 倍。
根据筛查方式,评估异常发现的影像学和有创性程序的使用情况有所不同,LDCT 的使用率低于 CXR。与基线筛查相比,后续筛查检查后的有创性和手术性检查较少。使用率与年龄较大相关,但与性别、种族或民族、保险状况或收入无关。